23Andme
Price & Volume
Stats
See more| Open | $0.42 |
| Previous Close | $0.43 |
| Day Range | $0.42-$0.43 |
| 52W Range | $0.35-$2.03 |
| Market Cap | $217.3M |
| Shares Short | 36M |
Financials
See more| Revenue (12 Mos) | $219.6M |
| Revenue Growth (YoY) | -30.7% |
| Gross Profit (12 Mos) | $132.9M |
| Diluted EPS | -$1.40 |
News
See moreYahoo Finance • 3 months ago
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
Yahoo Finance • 5 months ago
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
Yahoo Finance • 8 months ago
23andMe Reports Second Quarter Fiscal 2024 Financial Results
Yahoo Finance • 8 months ago
23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health Membership
About
| CEO | Ms. Anne Wojcicki |
| CFO | Mr. Joseph Selsavage |
| Address | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Full-Time Employees | 560 |
